Literature DB >> 15625645

Induction of autoimmune hepatitis by pegylated interferon alfa-2b in chronic hepatitis C.

Julia Lörke1, Andreas Erhardt, Dieter Häussinger.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15625645     DOI： 10.1016/s1542-3565(04)00446-x

Source DB:  PubMed          Journal:  Clin Gastroenterol Hepatol        ISSN： 1542-3565            Impact factor:   11.382


× No keyword cloud information.
  5 in total

1.  Marked flare in hepatic aminotransferases during treatment with pegylated interferon for chronic hepatitis C, genotype 2: a case report.

Authors:  Poonam Mishra; Amanda DeVoss; Rish Pai; John Hart; Donald M Jensen
Journal:  Dig Dis Sci       Date:  2008-09-04       Impact factor: 3.199

Review 2.  Era of direct acting antivirals in chronic hepatitis C: Who will benefit?

Authors:  James Fung
Journal:  World J Hepatol       Date:  2015-10-28

3.  Alanine aminotransferase elevation during peginterferon alpha-2a or alpha-2b plus ribavirin treatment.

Authors:  Masato Nakamura; Tatsuo Kanda; Tatsuo Miyamura; Shuang Wu; Shingo Nakamoto; Osamu Yokosuka
Journal:  Int J Med Sci       Date:  2013-06-15       Impact factor: 3.738

4.  Concurrent autoimmune hepatitis and grave's disease in hepatitis C during pegylated interferon α-2a and ribavirin therapy.

Authors:  Guru V Trikudanathan; Imad Ahmad; Jonathan L Israel
Journal:  Saudi J Gastroenterol       Date:  2011 Sep-Oct       Impact factor: 2.485

5.  Autoimmune Hepatitis Triggered by Treatment With Pegylated Interferon α-2a and Ribavirin for Chronic Hepatitis C.

Authors:  Chetan Rathi; Nirav Pipaliya; Dhaval Choksi; Pathik Parikh; Meghraj Ingle; Prabha Sawant
Journal:  ACG Case Rep J       Date:  2015-07-09
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.